FDA Issues Multiple Warnings Against Transvaginal Mesh
The U.S. Food and Drug Administration (FDA) has issued not one, but multiple warnings against the use of a transvaginal mesh, the common name for the surgical mesh used to repair a pelvic organ prolapse (POP). According to the FDA, serious complications associated with the use of transvaginal mesh are “not rare” and, even more importantly, “it is not clear that transvaginal POP repair with mesh is more effective than traditional non-mesh repair in patients with POP and it may expose patients to greater risk.” (emphasis added).
Fears | Nachawati has committed significant resources to fighting for the women and families who have suffered as a result of the use of transvaginal mesh. The FDA and other health agencies couldn’t be clearer on this: there’s very real risk! Nevertheless, some health providers continue to use them. Have you or a loved one been injured as a result of the application of a transvaginal mesh? Find out about your legal options today!
For your free consultation, call us at 1.866.545.8364 or email mn@fnlawfirm.com. Let us fight for you!
